section name header

Indications ⬇

REMS


Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Interactions ⬆ ⬇

Drug-drug:

Availability ⬆ ⬇

(Generic available)

Route/Dosage ⬆ ⬇

US Brand Names ⬆ ⬇

Dificid

Action ⬆ ⬇

  • Bactericidal action mostly against clostridia; inhibits RNA synthesis.
  • Acts locally in the GI tract to eliminate Clostridioides difficile.
Therapeutic effects:
  • Elimination of diarrhea caused by Clostridioides difficile.

Classifications ⬆ ⬇

Therapeutic Classification: anti-infectives

Pharmacologic Classification: macrolides

Pharmacokinetics ⬆ ⬇

Absorption: Minimal systemic absorption.

Distribution: Stays primarily in the GI tract.

Metabolism/Excretion: Mostly transformed via hydrolysis in the GI tract to OP-1118, its active metabolite. Eliminated mostly (>92%) in feces: <1% excreted in urine.

Half-Life: Fidaxomicin: 11.7 hr; OP-1118: 11.2 hr.

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
POunknownunknownunknown

Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆ ⬇

fi-dax-oh-MYE-sin

Code ⬆

NDC Code